<DOC>
	<DOCNO>NCT00987662</DOCNO>
	<brief_summary>Objective : 1 . To study effectiveness irbesartan 300mg amlodipine 10 mg 24h ambulatory blood pressure value obese subject 2 . To study drug specific effect arterial stiffness 3 . To study possible drug mechanism obesity ( reduction central adiposity change ratio leptin adiponectin )</brief_summary>
	<brief_title>Irbesartan Versus Amlodipine : The OBI Study</brief_title>
	<detailed_description>Study Objectives 1 . Primary : - Reduction 24h BP obese hypertensive - Reduction arterial stiffness 2 . Secondary - Drug specific effect new onset diabetes - Drug specific effect reduction central fat deposition leptin adiponectin ratio Study design Study drug : Irbesartan 300mg vs. amlodipine 10mg Tx duration follow-up : 12 month Collected data : - 24h SBP DBP time 0 , 1 , 12 . - Pulse wave velocity time 0,1,12 . - Central obesity ( total , visceral , abdominal fat ) time 0,1,12 . - Leptin/adiponectin time 0,1,12 . - BMI , waist/hip ratio time 0,1 , 12 . - Glu , HbA1c , insulin time 0 , 1,12 . - K , Na , Cr , BUN , Chol , Tg , HDL , LDL , ALT , AST time 0 , 1,12 . Number patient : The reduction mean SBP expect 15 mmHg . Previous study group report 14mmHg SD mean SBP . The sample size require two side 5 % significance level 80 % power 40 patient ( Lehr 's formula ) Number center : 1</detailed_description>
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Age 18 60 year . 2 . All patient go give inform consent participate study . 3 . Stage I hypertension . 4 . BMI &gt; 30 . 1 . Known oversensitiveness , 2 . Chronic renal disease ( GFR &lt; 50 ml/min ) ESRD , 3 . Heart respiratory failure , OR 4 . Recent MI , shock , liver deficiency ( ALT AST &gt; 3 time normal pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>irbesartan</keyword>
	<keyword>amlodipine</keyword>
	<keyword>obesity</keyword>
	<keyword>ambulatory blood pressure monitoring</keyword>
	<keyword>new onset diabetes</keyword>
</DOC>